Zimmer Biomet Holdings Inc (ZBH) : Baskin Financial Services scooped up 2,270 additional shares in Zimmer Biomet Holdings Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 3, 2016. The investment management firm now holds a total of 94,775 shares of Zimmer Biomet Holdings Inc which is valued at $10,937,035.Zimmer Biomet Holdings Inc makes up approximately 3.18% of Baskin Financial Services’s portfolio.
Other Hedge Funds, Including , Cambridge Investment Research Advisors boosted its stake in ZBH in the latest quarter, The investment management firm added 5,037 additional shares and now holds a total of 12,071 shares of Zimmer Biomet Holdings Inc which is valued at $1,392,993. Zimmer Biomet Holdings Inc makes up approx 0.03% of Cambridge Investment Research Advisors’s portfolio.Gamble Jones Investment Counsel reduced its stake in ZBH by selling 210 shares or 2.22% in the most recent quarter. The Hedge Fund company now holds 9,245 shares of ZBH which is valued at $1,066,873. Zimmer Biomet Holdings Inc makes up approx 0.12% of Gamble Jones Investment Counsel’s portfolio.American Century Companies Inc boosted its stake in ZBH in the latest quarter, The investment management firm added 52,313 additional shares and now holds a total of 2,969,530 shares of Zimmer Biomet Holdings Inc which is valued at $342,683,762. Zimmer Biomet Holdings Inc makes up approx 0.40% of American Century Companies Inc’s portfolio. Polaris Greystone Financial Group added ZBH to its portfolio by purchasing 4,411 company shares during the most recent quarter which is valued at $510,661. Zimmer Biomet Holdings Inc makes up approx 0.08% of Polaris Greystone Financial Group’s portfolio.Old Second National Bank Of Aurora reduced its stake in ZBH by selling 400 shares or 51.95% in the most recent quarter. The Hedge Fund company now holds 370 shares of ZBH which is valued at $42,461. Zimmer Biomet Holdings Inc makes up approx 0.02% of Old Second National Bank Of Aurora’s portfolio.
Zimmer Biomet Holdings Inc opened for trading at $116.52 and hit $117.48 on the upside on Tuesday, eventually ending the session at $117.38, with a gain of 0.82% or 0.95 points. The heightened volatility saw the trading volume jump to 9,22,366 shares. Company has a market cap of $23,339 M.
On the company’s financial health, Zimmer Biomet Holdings Inc reported $2.00 EPS for the quarter, beating the analyst consensus estimate by $ 0.07 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $1.93. The company had revenue of $1904.00 million for the quarter, compared to analysts expectations of $1878.31 million. The company’s revenue was up 67.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.54 EPS.
Many Wall Street Analysts have commented on Zimmer Biomet Holdings Inc. Company shares were Reiterated by Barclays on Apr 29, 2016 to “Overweight”, Firm has raised the Price Target to $ 135 from a previous price target of $130 .Company shares were Reiterated by RBC Capital Mkts on Apr 15, 2016 to “Outperform”, Firm has raised the Price Target to $ 132 from a previous price target of $120 .Zimmer Biomet Holdings Inc was Initiated by Nomura to “Buy” on Mar 17, 2016.
Zimmer Biomet Holdings Inc. formerly Zimmer Holdings Inc. is a musculoskeletal healthcare company. The Company designs manufactures and markets orthopedic reconstructive products; sports medicine biologics extremities and trauma products; spine bone healing craniomaxillofacial and thoracic products; dental implants and related surgical products. The Company manages its operations through three geographic segments: the Americas comprising principally of the United States and includes other North Central and South American markets; Europe comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers and directly to dental practices and dental laboratories.